$AIZ

Lonergan Robert sold $1.8M of AIZ

Lonergan Robert (EVP, CSTO) sold 7,000 shares of ASSURANT, INC. (AIZ) at $262.71 ($1.84M total) on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lonergan Robert
Published Jun 23, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIZ
Neutral
medium confidence
Mentioned
$AIZ
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIZNeutralLow
01

Why it matters

The disclosed sale is specific (7,000 shares; ~$1.84M) and executed under a pre-arranged 10b5-1 plan, which typically reduces informational content.

02

Market read

Traders may note the insider sale for sentiment/positioning, but it is unlikely to drive a fundamental repricing alone.

03

What to watch

The filing does not indicate motive, tax planning, or diversification needs; 10b5-1 sales are frequently scheduled regardless of near-term outlook.

Relevance 5/10Novelty 5/10Timing: Filed after-hours on 2026-06-23; reflects sale executed 2026-06-22.

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Assurant, Inc.

Company-level read

Ticker impact

$AIZNeutralMedium confidence
Context

Assurant (AIZ) disclosed an EVP’s $1.84M open-market sale of 7,000 shares at $262.7097 on a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

Form 4 provides a concrete transaction size and price, but insider sales under a pre-arranged 10b5-1 plan are often interpreted as non-informational.

Market effects

Minimal; single-company insider transaction with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be read as reduced confidence, especially if paired with other negative disclosures (not present here).

Key entities

  • ASSURANT, INC.

    Subject of the Form 4 insider transaction disclosure.

  • Lonergan Robert

    EVP, CSTO who sold 7,000 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIZMedAI 8/10

Assurant (AIZ) Q2 2026 Earnings Call Transcript

Assurant (AIZ) reported Q2 2026 results in an earnings call transcript. Adjusted EBITDA excluding catastrophes rose 18% to $491.4M, and adjusted EPS excluding catastrophes grew 19% to $6.60. Net earned premiums, fees and other income increased 9% to $3.32B. The company revised full-year adjusted EBITDA guidance to mid-single-digit growth and reported $911M liquidity plus $75M Q2 share repurchases.

$AIZMedAI 8/10

Why Assurant (AIZ) Stock Is Trading Up Today

Assurant (AIZ) shares rose about 6.3% after the company reported Q2 2026 results that beat Wall Street. Adjusted EPS was $6.41, above the $5.18 estimate, and up 23.7% year over year. Revenue increased 9.5% to $3.45 billion. Pre-tax margin rose to 10.9%.

$AIZMed

Assurant: Q2 Earnings Snapshot

Assurant Inc. (AIZ) reported Q2 profit of $298.6 million, or $5.95 per share. Adjusted earnings were $6.41 per share versus Zacks’ estimate of $5.16. Revenue was $3.45 billion, with adjusted revenue $3.46 billion versus $3.4 billion expected. Shares were $281.31 at Tuesday’s close.